Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.

Liu L, Wang J, Li X, Ma J, Shi C, Zhu H, Xi Q, Zhang J, Zhao X, Gu M.

Biochem Biophys Res Commun. 2015 Feb 20;457(4):621-6. doi: 10.1016/j.bbrc.2015.01.037. Epub 2015 Jan 17.

PMID:
25603050
2.

miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.

Ma X, Wei J, Zhang L, Deng D, Liu L, Mei X, He X, Tian J.

Biomed Pharmacother. 2016 May;80:220-226. doi: 10.1016/j.biopha.2016.03.020. Epub 2016 Mar 28.

PMID:
27133060
3.

miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.

Li R, Liu J, Li Q, Chen G, Yu X.

Tumour Biol. 2016 Mar;37(3):3987-96. doi: 10.1007/s13277-015-4165-9. Epub 2015 Oct 19.

PMID:
26482618
4.

MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1.

Li R, Dong B, Wang Z, Jiang T, Chen G.

Biomed Pharmacother. 2018 Jun;102:988-995. doi: 10.1016/j.biopha.2018.03.122. Epub 2018 Apr 5.

PMID:
29710554
5.

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.

Ma Y, Qin H, Cui Y.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):958-63. doi: 10.1016/j.bbrc.2013.11.010. Epub 2013 Nov 9.

PMID:
24220341
6.

Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.

Czajka AA, Wójcicka A, Kubiak A, Kotlarek M, Bakuła-Zalewska E, Koperski Ł, Wiechno W, Jażdżewski K.

PLoS One. 2016 Mar 24;11(3):e0151968. doi: 10.1371/journal.pone.0151968. eCollection 2016.

7.

MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.

Dong S, Jin M, Li Y, Ren P, Liu J.

Oncol Rep. 2016 Apr;35(4):2151-8. doi: 10.3892/or.2016.4604. Epub 2016 Feb 1.

PMID:
26847706
8.

miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.

Wen Q, Zhao J, Bai L, Wang T, Zhang H, Ma Q.

Oncol Rep. 2015 Oct;34(4):2202-10. doi: 10.3892/or.2015.4165. Epub 2015 Jul 31.

PMID:
26239517
9.

MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.

Zhang X, Li D, Li M, Ye M, Ding L, Cai H, Fu D, Lv Z.

Int J Cancer. 2014 Jan 15;134(2):257-67. doi: 10.1002/ijc.28141. Epub 2013 Sep 18.

10.

miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.

Ma S, Jia W, Ni S.

Biochem Biophys Res Commun. 2018 Feb 26;497(1):181-186. doi: 10.1016/j.bbrc.2018.02.051. Epub 2018 Feb 8.

PMID:
29427661
11.

miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.

Wei C, Song H, Sun X, Li D, Song J, Hua K, Fang L.

Oncol Rep. 2015 Jul;34(1):211-20. doi: 10.3892/or.2015.3971. Epub 2015 May 11.

PMID:
26063221
12.

LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.

Wang X, Lu X, Geng Z, Yang G, Shi Y.

J Cell Biochem. 2017 Dec;118(12):4745-4752. doi: 10.1002/jcb.26142. Epub 2017 Jun 22.

PMID:
28513866
13.

Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.

Jahanbani I, Al-Abdallah A, Ali RH, Al-Brahim N, Mojiminiyi O.

Thyroid. 2018 Mar;28(3):319-327. doi: 10.1089/thy.2017.0127. Epub 2018 Mar 2.

PMID:
29378472
14.

MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma.

Diao Y, Fu H, Wang Q.

Am J Ther. 2017 May;24(3):e317-e328. doi: 10.1097/MJT.0000000000000420.

15.

miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.

Zhu H, Fang J, Zhang J, Zhao Z, Liu L, Wang J, Xi Q, Gu M.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):857-62. doi: 10.1016/j.bbrc.2014.06.073. Epub 2014 Jun 24.

PMID:
24971532
16.

MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.

Qiu W, Yang Z, Fan Y, Zheng Q.

Oncotarget. 2016 Jun 28;7(26):39907-39915. doi: 10.18632/oncotarget.9530.

17.

MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.

Song HM, Luo Y, Li DF, Wei CK, Hua KY, Song JL, Xu H, Maskey N, Fang L.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9889-900. eCollection 2015.

18.

Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.

Xia F, Chen Y, Jiang B, Du X, Peng Y, Wang W, Huang W, Feng T, Li X.

Cell Physiol Biochem. 2018;50(5):1659-1672. doi: 10.1159/000494786. Epub 2018 Nov 1.

19.

Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).

Jazdzewski K, Boguslawska J, Jendrzejewski J, Liyanarachchi S, Pachucki J, Wardyn KA, Nauman A, de la Chapelle A.

J Clin Endocrinol Metab. 2011 Mar;96(3):E546-53. doi: 10.1210/jc.2010-1594. Epub 2010 Dec 15.

20.

miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.

Lv M, Zhang X, Li M, Chen Q, Ye M, Liang W, Ding L, Cai H, Fu D, Lv Z.

PLoS One. 2013 Jul 5;8(7):e67591. doi: 10.1371/journal.pone.0067591. Print 2013.

Supplemental Content

Support Center